Autres langues Cibus, Inc. Nasdaq

Actions

CLXT

US17166A1016

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 21/09/2026			Varia. 5j.	Varia. 1 janv.
1,560 ^USD	-3,11%		+4,70%	-10,34%

13/08	Transcript : Cibus, Inc., Q2 2026 Earnings Call, Aug 13, 2026
13/08	Cibus, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

13/08	Cibus: Q2 Earnings Snapshot
13/08	Cibus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
09/06	Cibus, Inc. Announces Board Changes, Effective June 8, 2026
09/06	Cibus, Inc. Announces CEO Changes, Effective June 8, 2026
15/05	Cibus Inc to offer securities with aggregate initial offering price up to $200 million - SEC filing
14/05	Cibus: Q1 Earnings Snapshot
14/05	Cibus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
04/05	Cibus, Inc. Transfers Gene-Edited Herbicide Tolerance Materials to Interoc for Testing and Production of Cibus Enhanced Seed Products in Latin America
10/04	Cibus, Inc. Announces Appointment of Thomas Urban as A Member of the Board, Effective April 7, 2026
25/03	Cibus, Inc. announces proposed public offering of class A common stock and pre-funded warrants
17/03	Cibus: Q4 Earnings Snapshot
17/03	Cibus, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
17/03	Cibus, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2025
17/03	Cibus, Inc. Auditor Raises 'Going Concern' Doubt
29/01	Cibus, Inc. announces pricing of $20.0 million public offering of class A common stock
29/01	Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock
28/01	Cibus announces proposed public offering of class A common stock
05/01	Cibus, Inc. and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets Across Latin America
05/01	Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
13/11	Gene editing firm Cibus misses Q3 revenue estimates
13/11	Cibus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Cibus: Q3 Earnings Snapshot
10/11	Cibus, Inc. Appoints Craig Wichner as Member of the Board and Member of the Board?S Standing Strategy Committee, Effective November 5, 2025
30/10/25	Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
16/10/25	Cibus and AgVaya Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing